Hamed Mirzaei

73.9k total citations · 6 hit papers
359 papers, 17.9k citations indexed

About

Hamed Mirzaei is a scholar working on Molecular Biology, Cancer Research and Immunology. According to data from OpenAlex, Hamed Mirzaei has authored 359 papers receiving a total of 17.9k indexed citations (citations by other indexed papers that have themselves been cited), including 210 papers in Molecular Biology, 136 papers in Cancer Research and 38 papers in Immunology. Recurrent topics in Hamed Mirzaei's work include MicroRNA in disease regulation (105 papers), Circular RNAs in diseases (75 papers) and Cancer-related molecular mechanisms research (56 papers). Hamed Mirzaei is often cited by papers focused on MicroRNA in disease regulation (105 papers), Circular RNAs in diseases (75 papers) and Cancer-related molecular mechanisms research (56 papers). Hamed Mirzaei collaborates with scholars based in Iran, United States and South Africa. Hamed Mirzaei's co-authors include Amirhossein Sahebkar, Hamid Reza Mirzaei, Michael R. Hamblin, Aria Masoudifar, Majid Darroudi, Javid Sadri Nahand, Mohammad Hossein Pourhanifeh, Bahman Rashidi, Zatollah Asemi and Mahmoud Reza Jaafari and has published in prestigious journals such as Proceedings of the National Academy of Sciences, SHILAP Revista de lepidopterología and Journal of Molecular Biology.

In The Last Decade

Hamed Mirzaei

351 papers receiving 17.7k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Zinc oxide nanoparticles: Biological synthesis and biomedical applications

2016 626 citations Hamed Mirzaei et al. profile →
Phytosomal curcumin: A review of pharmacokinetic, experimental and clinical studies

2016 422 citations Hamed Mirzaei, Amin Jalili et al. profile →
NLRP3 inflammasome: Its regulation and involvement in atherosclerosis

2017 386 citations Hamed Mirzaei et al. profile →
Breast cancer diagnosis: Imaging techniques and biochemical markers

2017 348 citations Arash Salmaninejad, Javid Sadri Nahand et al. profile →
Chitosan-based nanoparticles against bacterial infections

2020 318 citations Hossein Tarrahimofrad, Mohammad Saeid Ebrahimi et al. profile →
Paxlovid (Nirmatrelvir/Ritonavir): A new approach to Covid-19 therapy?

2023 88 citations Amirhossein Sheida, Mohammad Taghizadieh et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Hamed Mirzaei Iran	79	10.3k	6.4k	1.9k	1.7k	1.3k	359	17.9k
Didier Merlin United States	72	6.8k 0.7×	2.2k 0.4×	2.6k 1.4×	1.7k 1.0×	1.1k 0.8×	243	15.3k
Shaker A. Mousa United States	73	9.6k 0.9×	2.7k 0.4×	1.8k 1.0×	3.2k 1.8×	1.9k 1.4×	665	24.6k
Behzad Baradaran Iran	70	11.7k 1.1×	5.3k 0.8×	3.3k 1.8×	4.1k 2.4×	3.2k 2.4×	648	21.2k
Chandan K. Sen United States	82	9.5k 0.9×	3.1k 0.5×	2.1k 1.1×	1.0k 0.6×	1.6k 1.2×	404	26.0k
Gregory J. Anderson Australia	74	6.8k 0.7×	1.7k 0.3×	1.3k 0.7×	1.2k 0.7×	2.6k 2.0×	276	21.3k
Yan Li China	64	8.1k 0.8×	2.4k 0.4×	1.4k 0.7×	1.7k 1.0×	1.4k 1.1×	736	17.9k
Bahman Yousefi Iran	54	5.5k 0.5×	1.9k 0.3×	864 0.5×	1.4k 0.8×	1.1k 0.9×	266	11.3k
Kamal Dua Australia	59	5.3k 0.5×	1.6k 0.2×	1.3k 0.7×	808 0.5×	1.8k 1.3×	627	16.0k
Mehdi Yousefi Iran	61	4.9k 0.5×	1.5k 0.2×	3.3k 1.8×	1.4k 0.8×	1.4k 1.1×	393	13.3k
Mehdi Shakibaei Germany	72	5.3k 0.5×	1.7k 0.3×	1.0k 0.6×	1.3k 0.8×	1.1k 0.8×	260	14.7k

Countries citing papers authored by Hamed Mirzaei

Since Specialization

Citations

This map shows the geographic impact of Hamed Mirzaei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hamed Mirzaei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hamed Mirzaei more than expected).

Fields of papers citing papers by Hamed Mirzaei

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hamed Mirzaei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hamed Mirzaei. The network helps show where Hamed Mirzaei may publish in the future.

Co-authorship network of co-authors of Hamed Mirzaei

This figure shows the co-authorship network connecting the top 25 collaborators of Hamed Mirzaei. A scholar is included among the top collaborators of Hamed Mirzaei based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hamed Mirzaei. Hamed Mirzaei is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Mirzaei, Seyed Abbas, et al.. (2025). Metal nanoparticles and sensitivity/resistance to therapy in cancer: two sides of the coin?. Journal of Nanoparticle Research. 27(2).

Kesheh, Mina Mobini, Mohammad Yousef Memar, Hossein Bannazadeh Baghi, et al.. (2024). MicroRNAs and human viral diseases: A focus on the role of microRNA-29. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1871(1). 167500–167500. 10 indexed citations

Goleij, Pouya, Pantea Majma Sanaye, Mohammad Amin Khazeei Tabari, et al.. (2024). Phytostilbenes in lymphoma: Focuses on the mechanistic and clinical prospects of resveratrol, pterostilbene, piceatannol, and pinosylvin. Leukemia Research. 138. 107464–107464. 12 indexed citations

Sadeghi, Ehsan, et al.. (2024). Green Synthesis of Au-Doped Tin Oxide Nanoparticles Using Teucrium Polium Extract with Potential Applications in Photodynamic Therapy. Photobiomodulation Photomedicine and Laser Surgery. 42(10). 643–652.

Mirzaei, Hamed, et al.. (2024). Nanoemulsion and nanoencapsulation of a hydroethanolic extract of Nettle (Urtica dioica) and Wormwood (Artemisia absinthium): comparison of antibacterial and anticancer activity. Frontiers in Chemistry. 12. 1266573–1266573. 10 indexed citations

Hamblin, Michael R., et al.. (2023). In-silico characterization of a thermophilic serine protease via homology modeling, docking and molecular dynamics simulations. Journal of Biomolecular Structure and Dynamics. 43(3). 1206–1227. 2 indexed citations

Nahand, Javid Sadri, et al.. (2023). Evaluation of expression pattern of cellular miRNAs (let-7b, miR-29a, miR-126, miR-34a, miR-181a-5p) and IL-6, TNF-α, and TGF-β in patients with pseudoexfoliation syndrome. Pathology - Research and Practice. 249. 154721–154721. 12 indexed citations

Khatami, Alireza, Mohammad Taghizadieh, Javid Sadri Nahand, et al.. (2023). Evaluation of MicroRNA Expression Pattern (miR-28, miR-181a, miR-34a, and miR-31) in Patients with COVID-19 Admitted to ICU and Diabetic COVID-19 Patients. Intervirology. 66(1). 63–76. 12 indexed citations

Nahand, Javid Sadri, Mohammad Taghizadieh, Mohammad Saeid Ebrahimi, et al.. (2021). Oncogenic viruses and chemoresistance: What do we know?. Pharmacological Research. 170. 105730–105730. 33 indexed citations

10.

Rad, Niloofar Khoshdel, Hamed Mirzaei, Anastasia Shpichka, et al.. (2021). Evolution of organoid technology: Lessons learnt in Co-Culture systems from developmental biology. Developmental Biology. 475. 37–53. 36 indexed citations

11.

Shamshirian, Amir, Keyvan Heydari, Amir Reza Aref, et al.. (2020). Breast cancer risk factors in Iran: a systematic review & meta-analysis. Hormone Molecular Biology and Clinical Investigation. 41(4). 34 indexed citations

12.

Mirzaei, Hamed, et al.. (2020). Gene editing technology for improving life quality: A dream coming true?. Clinical Genetics. 99(1). 67–83. 2 indexed citations

13.

Vafadar, Asma, Zahra Shabaninejad, Ahmad Movahedpour, et al.. (2020). Quercetin and cancer: new insights into its therapeutic effects on ovarian cancer cells. Cell & Bioscience. 10(1). 32–32. 219 indexed citations

14.

Rezaei, Samaneh, Maryam Mahjoubin‐Tehran, Seyed Hamid Aghaee‐Bakhtiari, et al.. (2020). Autophagy-related MicroRNAs in chronic lung diseases and lung cancer. Critical Reviews in Oncology/Hematology. 153. 103063–103063. 57 indexed citations

15.

Vafadar, Asma, Zahra Shabaninejad, Ahmad Movahedpour, et al.. (2019). Long Non-Coding RNAs As Epigenetic Regulators in Cancer. Current Pharmaceutical Design. 25(33). 3563–3577. 108 indexed citations

16.

Nahand, Javid Sadri, Mohsen Moghoofei, Arash Salmaninejad, et al.. (2019). Pathogenic role of exosomes and microRNAs in HPV‐mediated inflammation and cervical cancer: A review. International Journal of Cancer. 146(2). 305–320. 187 indexed citations

17.

Khan, Haroon, Hamid Reza Mirzaei, Hamid Reza Mirzaei, et al.. (2019). Glyco-nanoparticles: New drug delivery systems in cancer therapy. Seminars in Cancer Biology. 69. 24–42. 63 indexed citations

18.

Abadi, Mohammad Hassan Jafari Najaf, Rana Shafabakhsh, Zatollah Asemi, et al.. (2019). CFIm25 and alternative polyadenylation: Conflicting roles in cancer. Cancer Letters. 459. 112–121. 28 indexed citations

19.

Tavakolizadeh, Jahanshir, Kambiz Roshanaei, Arash Salmaninejad, et al.. (2017). MicroRNAs and exosomes in depression: Potential diagnostic biomarkers. Journal of Cellular Biochemistry. 119(5). 3783–3797. 141 indexed citations

20.

Mirzaei, Hamed & Kristina Schmidt. (2012). Non-Bloom syndrome-associated partial and total loss-of-function variants of BLM helicase. Proceedings of the National Academy of Sciences. 109(47). 19357–19362. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact